Investor mix
6 investors on record; lead investors include Abingworth, MVM; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 3 | 50% |
De-coppering agent for the treatment of Wilson disease.
6 investors on record; lead investors include Abingworth, MVM; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 3 | 50% |